Clinical relevance of Acinetobacter baumannii ventilator-associated pneumonia

Critical Care Medicine

Volumn 31, Issue 10, 2003, Pages 2557-2559

  Montero, Abelardo ^a   Corbella, Xavier ^a   Ariza, Javier ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CARBAPENEM; COLISTIN; IMIPENEM;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTIFICIAL VENTILATION; BACTERIAL COLONIZATION; BACTERIAL PNEUMONIA; BACTERIAL STRAIN; BACTERIAL SURVIVAL; BACTERIAL TRANSMISSION; BACTERIAL VIRULENCE; BACTERIUM CULTURE; BACTERIUM ISOLATION; EDITORIAL; HOSPITAL INFECTION; HUMAN; INTENSIVE CARE; MORTALITY; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; RESPIRATORY TRACT INTUBATION;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANTI-BACTERIAL AGENTS; COLISTIN; CROSS INFECTION; HUMANS; PNEUMONIA, BACTERIAL; RESPIRATION, ARTIFICIAL;

EID: 0142088764     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000089937.38406.9F     Document Type: Editorial

References (11)

1. Bergogne-Bérézin E: Acinetobacter: A challenge to infection control. Acinetobacter 96. Paper presented at: 4th International Symposium on the biology of Acinetobacter, November 3-5, 1996, Eilat, Israel
2. Corbella X, Montero A, Pujol M, et al: Emergence and rapid spread of carbapenem resistance during a large and sustained hospital outbreak of multiresistant Acinetobacter baumannii. J Clin Microbiol 2000; 38:4086-4095
3. Chastre J, Fagon JY: Ventilator-associated pneumonia. Am J Respir Crit Care Med 2002; 165:867-903
4. Garnacho-Montero J, Ortiz-Leyva C, Jiménez-Jiménez FJ, et al: Treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia (VAP) with intravenous colistin: A comparison with imipenem-susceptible VAP. Clin Infect Dis 2003; 36:1111-1118
5. Trouillet JL, Chastre J, Vuagnat A, et al: Ventilator-associated pneumonia caused by potentially drug-resistant bacteria. Am J Respir Crit Care Med 1998; 157:531-539
6. Garnacho J, Sole-Violan J, Sa-Borges M, et al: Clinical impact of pneumonia caused by Acinetobacter baumannii in intubated patients: A matched cohort study. Crit Care Med 2003; 31:2478-2482
7. Wenzel RP: Perspective: Attributable mortality - The promise of better antimicrobial therapy. J Infect Dis 1998; 178:917-919
8. Montera A, Ariza J, Corbella X, et al: Efficacy of colistin versus β-lactams, aminoglycosides, and rifampin as monotherapy in a mouse model of pneumonia caused by multiresistant Acinetobacter baumannii. Antimicrob Agents Chemother 2002; 46:1946-1952
9. Kollef MH: An empirical approach to the treatment of multidrug-resistant ventilator-associated pneumonia. Clin Infect Dis 2003; 36:1119-1121
10. Wolff M, Joly-Guillou ML, Farinotti R, et al: In vivo efficacies of combinations of β-lactams, β-lactamase inhibitors and rifampin against Acinetobacter baumannii in a mouse pneumonia model. Antimicrob Agents Chemother 1999; 43:1406-1411
11. Montero A, Corbella X, Cabellos C, et al: Single and combined therapy against highly carbapenem resistant Acinetobacter baumannii in an immunocompetent mouse pneumonia model. Paper presented at: 41st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), American Society for Microbiology, December 2001, Chicago, IL (abstract no. 998)